Evaluating outcomes of Clareon Vivity lenses in patients with previous vision correction surgery
Official title: Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
Run by Utah Eye Centers · NCT06924944 · Data updated 2026-11-12
This study is testing how well Clareon Vivity lenses work for people with age-related cataracts who have previously had vision correction surgery like LASIK or PRK.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 35 (estimated) |
| Sponsor | Utah Eye Centers Academic / other |
| Locations | 1 site (Ogden, Utah) |
| Status | Recruiting |
| Started | January 20, 2025 |
| Main results expected | December 2025 |
| Study ends | April 2026 |
| Registry record updated | April 13, 2025 |
| Trial ID | NCT06924944 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals with bilateral age-related cataracts who have previously undergone uncomplicated myopic refractive surgery and meet specific visual acuity criteria.
✕Probably not a fit
Patients with significant ocular or systemic comorbidities that could affect visual acuity or contrast sensitivity are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the clinical outcomes of patients who have undergone bilateral cataract surgery using Clareon Vivity intraocular lenses (IOLs) after having previous myopic refractive surgery, such as LASIK or PRK. The study focuses on patients with age-related cataracts who are otherwise healthy and have a history of uncomplicated refractive surgery. By analyzing visual acuity and other outcomes post-surgery, the study seeks to provide insights into the effectiveness of these lenses in achieving good vision at various distances. The research is based on data from an international registry and aims to address the challenges faced by post-refractive surgery patients in achieving predictable visual outcomes.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of how Clareon Vivity lenses perform in patients with a history of refractive surgery, potentially leading to improved visual outcomes and greater spectacle independence.
How similar studies have gone: While this study builds on existing data regarding the effectiveness of Vivity IOLs, it specifically targets a unique patient population, making it a novel approach in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * o Bilateral age-related visually significant cataracts in otherwise healthy eyes, undergoing uncomplicated bilateral sequential Clareon Vivity IOLs * Prior history of uncomplicated post-refractive myopic surgery (LASIK/PRK) with up to 1 enhancement treatment * Potential acuity measured post-operatively 20/25 or better in both eyes * Patients with regular astigmatism that can be managed with T3 toric lens or arcuate incision Exclusion Criteria: * o Ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, etc. * Prior ocular surgeries other than uncomplicated corneal refractive surgery and excluding RK * Patients with irregular astigmatism/topography (to rule out signs of potential ectasia), corneal dystrophies, and pupil abnormalities * Total HOA cutoff of ≤0.5, coma ≤0.3 * RLE patients
Where it's running
-
Utah Eye Centers
Ogden, Utah, United States Recruiting
Study contacts
- Study coordinator: Rachel Buchanan
- Email: rbuchanan@utaheyecenters.com
- Phone: 8014099873
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Feasibility of using a head-mounted spatial display during intraocular surgery
This study tests whether Apple Vision Pro can help surgeons visualize information during cataract and other intraocular surgeries.
-
Lacrifill to Help Prevent Post-Curgery Dry Eye After Cataract Surgery
This study tests Lacrifill to see if it helps prevent dry eye symptoms after unilateral cataract surgery.
-
Shortening waiting time for cataract surgery
This project will try standard operating procedures to see if better coordination between wards and the operating room shortens waiting time for adults having cataract surgery.
-
Visual outcomes after cataract and refractive procedures
This project uses past clinical records to see how adults who had cataract surgery with an intraocular lens or refractive procedures fared in vision and refraction and to compare different IOLs and procedures.
-
Which eye drop—bromfenac, nepafenac, or diclofenac—works best after cataract surgery?
This trial will try three different anti-inflammatory eye drops (bromfenac 0.09%, nepafenac 0.3%, and diclofenac 0.1%) to see which best prevents or treats cystoid macular edema in adults having cataract surgery.
-
Effects of anxiety on satisfaction during cataract surgery
This study tests how anxiety affects pain and satisfaction during cataract surgery and whether taking Xanax before the procedure can help improve comfort for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.